[go: up one dir, main page]

SE8202172L - TOPICAL PHARMACEUTICAL COMPOSITIONS - Google Patents

TOPICAL PHARMACEUTICAL COMPOSITIONS

Info

Publication number
SE8202172L
SE8202172L SE8202172A SE8202172A SE8202172L SE 8202172 L SE8202172 L SE 8202172L SE 8202172 A SE8202172 A SE 8202172A SE 8202172 A SE8202172 A SE 8202172A SE 8202172 L SE8202172 L SE 8202172L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
skin
penetrable
difficultly
Prior art date
Application number
SE8202172A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
J Franz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/en
Priority claimed from CH2631/81A external-priority patent/CH647149A5/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8202172L publication Critical patent/SE8202172L/en
Priority to IT2330082U priority Critical patent/IT8223300V0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A skin penetration pharmaceutical composition incorporating a difficultly skin-penetrable pharmacologically active agent, wherein the composition is in the form of a microemulsion formed from skin compatible excipients.
SE8202172A 1981-04-06 1982-09-10 TOPICAL PHARMACEUTICAL COMPOSITIONS SE8202172L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT2330082U IT8223300V0 (en) 1982-04-29 1982-10-27 SERIES OF SIX MODELS OF RIGID METAL TUBULAR FRAMES WITH CURVED BENDS, COMBINABLE WITH HORIZONTAL PLATES OR PLANES AND CUSHIONS TO MAKE AS MANY FURNITURE (SUCH AS TABLES, SEATS, STOOLS, ARMCHAIRS) SUITABLE SUITABLE AS A BEDROOM.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (1)

Publication Number Publication Date
SE8202172L true SE8202172L (en) 1982-10-07

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8202172A SE8202172L (en) 1981-04-06 1982-09-10 TOPICAL PHARMACEUTICAL COMPOSITIONS

Country Status (16)

Country Link
AU (1) AU564570B2 (en)
CA (1) CA1192496A (en)
DE (1) DE3212053A1 (en)
DK (1) DK155882A (en)
ES (1) ES8308698A1 (en)
FI (1) FI821123L (en)
FR (1) FR2502951B1 (en)
GB (2) GB2098865B (en)
GR (1) GR75462B (en)
IL (1) IL65424A0 (en)
IT (1) IT8220611A0 (en)
MY (1) MY8600571A (en)
NL (1) NL8201413A (en)
NZ (1) NZ200232A (en)
PT (1) PT74703B (en)
SE (1) SE8202172L (en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (en) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (en) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner HIGHLY DISPERSAL PHARMACEUTICAL MULTI-COMPONENT SYSTEMS AND METHOD FOR THEIR PRODUCTION
AU578275B2 (en) * 1984-03-01 1988-10-20 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Pharmaceutical compositions
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (en) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk Anti-inflammatory and analgesic application agent
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (en) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate for the inhibition of acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (en) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh HIGH DISPERSES PHARMACEUTICAL COMPOSITION
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (en) * 1991-03-08 1993-06-11 Oreal USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS.
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (en) * 1991-05-20 2004-06-28 Novartis Ag. Compositions comprising allylamine derivatives, and process for their preparation
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
MX9207344A (en) * 1991-12-16 1993-07-01 Alza Corp IMPROVED FORMULATIONS THAT HAVE HYDROPHOBIC IMPROVERS OF TRANSDERMIC PENETRATION AND METHOD TO PROVIDE IT.
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
EP0642332B1 (en) 1992-05-13 1997-01-15 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (en) 1992-09-25 2002-06-16 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS.
EP0671937A4 (en) * 1992-10-16 1996-09-18 Smithkline Beecham Corp Pharmaceutical emulsion compositions.
EP0684832A4 (en) * 1993-02-17 1996-09-11 Smithkline Beecham Corp Microemulsions containing pharmaceutical compositions.
PT789580E (en) 1994-11-03 2002-09-30 Novartis Ag CYCLOSPORINE FORMULATIONS FOR ORAL ADMINISTRATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY AND PROCESS FOR ITS PRODUCTION
DE4442999A1 (en) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmaceutical composition containing an active loratidine metabolite
DE19549852B4 (en) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin containing preparations
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
EP0988046B1 (en) 1997-01-30 2004-09-15 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin a
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
IN188719B (en) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
UY25225A1 (en) 1997-10-29 2000-12-29 Smithkline Beecham Plc PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (en) * 1998-06-10 1999-12-16 Labtec Gmbh New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion
NZ512287A (en) * 1998-12-11 2002-12-20 Pharmasolutions Inc Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP1644004A4 (en) * 2003-06-20 2010-10-06 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
AU2004296784B2 (en) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (en) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． Steroid hormone pharmaceutical composition
EP3544614B1 (en) 2016-11-28 2025-12-31 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY
CA3107214A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (en) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (en) * 1977-01-14 1982-09-30 Sandoz Ag Method for producing new heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
GR75462B (en) 1984-07-20
NZ200232A (en) 1985-08-16
GB2098865A (en) 1982-12-01
FI821123A7 (en) 1982-10-07
AU8233482A (en) 1982-10-14
FR2502951B1 (en) 1985-12-06
IL65424A0 (en) 1982-07-30
FR2502951A1 (en) 1982-10-08
DE3212053A1 (en) 1982-10-21
ES511169A0 (en) 1983-10-01
ES8308698A1 (en) 1983-10-01
IT8220611A0 (en) 1982-04-06
PT74703A (en) 1982-05-01
GB2148711B (en) 1985-12-18
NL8201413A (en) 1982-11-01
FI821123A0 (en) 1982-03-31
AU564570B2 (en) 1987-08-20
GB2148711A (en) 1985-06-05
DK155882A (en) 1982-12-10
FI821123L (en) 1982-10-07
PT74703B (en) 1984-05-30
GB2098865B (en) 1985-12-18
CA1192496A (en) 1985-08-27
MY8600571A (en) 1986-12-31
GB8408654D0 (en) 1984-05-16

Similar Documents

Publication Publication Date Title
SE8202172L (en) TOPICAL PHARMACEUTICAL COMPOSITIONS
ATE46080T1 (en) PHARMACEUTICAL COMPOSITION.
DE3586545D1 (en) INCREASED PAINLESSNESS PHARMACEUTICAL COMPOSITIONS.
IT7928464A0 (en) PHARMACEUTICAL COMPOSITION HAVING ANTI-CANCER ACTIVITY.
EP0230575A3 (en) Medicament active against tumours, containing hexadecylphosphocholine
SE8504945L (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTRACYCLING GYCOSIDES
FI872808A7 (en) Novel topically administered pharmaceutical compositions with systemic effect.
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
DK0460062T3 (en) Huperzin A analogues
NO166281C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 1,1-DISUBSTITUTED CYCLOPROPANDER DERIVATIVES.
DE3484904D1 (en) MEDICINAL COMPOSITIONS OF REDUCED TOXICITY.
IT7927614A0 (en) 1,2,4,5-TETRA-ALKYL-4-ARYLPIPERIDINES AND RELATED PHARMACEUTICAL FORMULATIONS.
GB2021409A (en) Pharmaceutical composition
FI853228A7 (en) Novel -butyrolactams, their pharmaceutically active compositions, methods for their preparation and their use as pharmaceuticals.
SE8002642L (en) ANALGETIC AND MYOTONOLYTIC PREPARATIONS
FR2434804A1 (en) N-PHENYL-INDOLIN DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
IT7926854A0 (en) CREATINOL O-PHOSPHATE DERIVATIVE WITH THERAPEUTIC ACTION, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
NL930014I2 (en) 2,4-Dichloro-alpha (N-imidazolylmethyl) -dibenzyl ether derivative and a pharmaceutical composition comprising this compound.
SE7603223L (en) 13,14-DEHYDRO-11-DEOXI-PROSTAGLANDINS AND PROCEDURES FOR THEIR PREPARATION
DE3869156D1 (en) FUNGICIDE 2-ANILINTHIAZOLINE.
IT7822316A0 (en) PHARMACEUTICAL COMPOSITION FOR THE ADMINISTRATION OF PANCREATIN.
SE8704240L (en) ANALGETIC PREPARATIONS
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
SE8800461L (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8202172-6

Effective date: 19880112

Format of ref document f/p: F